FDA issues two Draft Guidances for Industry on Social Media and Internet Communications
??“????????(??)”?????????,??????????????,???????????????,???????
??????????????????????????
?????????????????????????????????
The FDA has just issued two draft guidances for industry with recommendations to help manufacturers and their representatives to accurately communicate online about prescription drugs and medical devices.
These documents aim at ensuring that the information provided by drug and medical device companies is accurate and help patients to make well-informed decisions in consultation with their health care providers.
The first Guidance provides recommendations for the presentation of risk and benefit information for prescription drugs or medical devices in case of usage of Internet and/or other social media sources
The Second Guidance provides recommendations to companies that choose to correct third-party information related to their own prescription drugs and medical devices.
The Guidances above will be examined in depth in next newsletter.